The role of Stenotrophomonas maltophilia in refractory chronic rhinosinusitis

American Journal of Rhinology and Allergy

Volumn 24, Issue 3, 2010, Pages 200-204

  Grindler, David ^a   Thomas, Charles ^b   Hall, Geraldine S ^c   Batra, Pete S ^d  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Antibiotics; Bacterial infection; Chronic rhinosinusitis; Drug resistance; Microbes; Refractory sinusitis; Stenotrophomonas maltophilia

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFAZOLIN; COTRIMOXAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHRONIC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOSCOPIC SINUS SURGERY; FEMALE; FOLLOW UP; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; NASAL LAVAGE; PUS; REFRACTORY PERIOD; RETROSPECTIVE STUDY; RHINOSINUSITIS; SEX RATIO; STENOTROPHOMONAS MALTOPHILIA; SURVIVAL TIME; SYMPTOM; TREATMENT DURATION;

CHRONIC DISEASE; DISEASE PROGRESSION; DRUG RESISTANCE; FEMALE; FLUOROQUINOLONES; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; PARANASAL SINUSES; RHINITIS; SINUSITIS; STENOTROPHOMONAS MALTOPHILIA; SUPPURATION; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 77953644299     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2010.24.3466     Document Type: Article

References (21)

1. Rosenfeld RM, Andes D, Bhattacharyya N, et al. Clinical practice guideline: Adult sinusitis. Otolaryngol Head Neck Surg 137:S1-S31, 2007.
2. Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: Definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 129:S1-S32, 2003.
3. Bolger WE. Gram negative sinusitis: An emerging clinical entity. Am J Rhinol 8:279-284, 1994.
4. Biel MA, Brown CA, Levinson RM, et al. Evaluation of the microbiology of chronic maxillary sinusitis. Ann Otol Rhinol Laryngol 107: 942-945, 1998.
5. Brook I, Thompson DH, and Frazier EH. Microbiology and management of chronic maxillary sinusitis. Arch Otolaryngol Head Neck Surg 120:1317-1320, 1994.
6. Nadel DM, Lanza DC, and Kennedy DW. Endoscopically guided cultures in chronic sinusitis. Am J Rhinol 12:233-241, 1998.
7. Subramanian H, Schechtman KB, and Hamilos DL. A retrospective analysis of treatment outcomes and time to relapse after intensive medical treatment for chronic rhinosinusitis. Am J Rhinol 16:303-312, 2002.
8. Hsu J, Lanza DC, and Kennedy DW. Antimicrobial resistance in bacterial chronic sinusitis. Am J Rhinol 12:243-248, 1998.
9. Kingdom TT, and Swain RE Jr. The microbiology and antimicrobial resistance patterns in chronic rhinosinusitis. Am J Otolaryngol 25: 323-328, 2004.
10. Bhattacharyya N, and Kepnes L. Assessment of trends in antimicrobial resistance in chronic rhinosinusitis. Ann Otol Rhinol Laryngol 117:448-452, 2008.
11. Bhattacharyya N, and Kepnes L. The microbiology of recurrent rhinosinusitis after endoscopic sinus surgery. Otolaryngol Head Neck Surg 125:1117-1120, 1999. (Pubitemid 29473375)
12. Coffey CS, Sonnenburg RE, Melroy CT, et al. Endoscopically guided aerobic cultures in postsurgical patients with chronic rhinosinusitis. Am J Rhinol 20:172-176, 2006.
13. Denton M, and Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 11:57-80, 1998.
14. Looney WJ. Role of Stenotrophomonas maltophilia in hospital-acquired infection. Br J Biomed Sci 62:145-154, 2005.
15. Morrison AJ, Hoffman KF, and Weizel RP. Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital. J Clin Microbiol 24:52-55, 1986.
16. Hulisz DT, and File TM. Predisposing factors and antibiotic use in nosocomial infections caused by Xanthomonas maltophilia. Infect Control Hosp Epidemiol 13:489-490, 1992.
17. Ansari SR, Hanna H, Hachem R, et al. Risk factors for infections with multidrug resistant Stenotrophomonas maltophilia in Patients with Cancer. Cancer 109:2615-2622, 2007.
18. Gales AC, Jones RN, Forward KR, et al. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis 15:S104-S113, 2001.
19. Desrosiers MY, and Kilty SJ. Treatment alternatives for chronic rhinosinusitis persisting after ESS: What to do when antibiotics, steroids and surgery fail. Rhinology 46:3-14, 2008.
20. Falagas ME, Kastoris AC, et al. Community-acquired Stenotrophomonas maltophilia infections: A systematic review. Eur J Clin Microbiol Infect Dis 28:719-730, 2009.
21. del Toro MD, Rodriguez-Baño J, Martínez-Martínez L, et al. Clinical epidemiology of Stenotrophomonas maltophilia colonization and infection. A multicenter study. Medicine 81:228-239, 2002.